Assessment of beta-cell function and insulin secretion in subjects that underwent renal transplantation

被引:0
作者
Tura, Andrea [1 ]
Hecking, Manfred [2 ]
Wolzt, Michael [3 ]
Saemann, Marcus D. [4 ]
Pacini, Giovanni [1 ]
机构
[1] CNR, Inst Neurosci, Corso Stati Uniti 4, I-35127 Padua, Italy
[2] Med Univ Vienna, Clin Div Nephrol, Vienna, Austria
[3] Med Univ Vienna, Clin Pharmacol, Vienna, Austria
[4] Med Univ Vienna, Clin Div Nephrol, Vienna, Austria
来源
2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC) | 2015年
关键词
ORAL GLUCOSE-TOLERANCE; FASTING PLASMA-GLUCOSE; C-PEPTIDE; TESTS; RESISTANCE; DYSFUNCTION; KIDNEY; RISK; MEAL;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this study we aimed to assess the performance of various indices of beta-cell function derived from oral glucose tolerance test (OGTT) in subjects that underwent renal transplantation. Impaired insulin secretion seems in fact central for development of new onset diabetes after transplantation, but its assessment has not been systematically evaluated. Twenty subjects underwent a 75 g 2h-OGTT for measurement of glucose, insulin, C-peptide. OGTT indices of beta-cell function were either derived by mathematical modeling (yielding the reference index: glucose sensitivity) or were empirical: insulinogenic index (IGI), IGI derived indices, whole shape C-peptide (WHOSH_CP). Indices of beta cell function, showed significant correlation with glucose sensitivity (R-2 =0.40-0.86, all P<0.003). The majority of beta-cell function indices provided comparable results also when subjects were divided into subgroups according to sex, age, body mass index, mean glycemia. In conclusion, in transplanted subjects OGTT empirical indices are typically acceptable for the estimation of beta-cell function.
引用
收藏
页码:2371 / 2374
页数:4
相关论文
共 21 条
[2]  
[Anonymous], KIDNEY RES CLIN PRAC
[3]   Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes [J].
Mari, A ;
Sallas, WM ;
He, YL ;
Watson, C ;
Ligueros-Saylan, M ;
Dunning, BE ;
Deacon, CF ;
Holst, JJ ;
Foley, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4888-4894
[4]   Assessing insulin secretion by modeling in multiple-meal tests - Role of potentiation [J].
Mari, A ;
Tura, A ;
Gastaldelli, A ;
Ferrannini, E .
DIABETES, 2002, 51 :S221-S226
[5]   Meal and oral glucose tests for assessment of β-cell function:: modeling analysis in normal subjects [J].
Mari, A ;
Schmitz, O ;
Gastaldelli, A ;
Oestergaard, T ;
Nyholm, B ;
Ferrannini, E .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (06) :E1159-E1166
[6]   β-cell function assessment from modelling of oral tests: an effective approach [J].
Mari, A. ;
Ferrannini, E. .
DIABETES OBESITY & METABOLISM, 2008, 10 :77-87
[7]   HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J].
MATTHEWS, DR ;
HOSKER, JP ;
RUDENSKI, AS ;
NAYLOR, BA ;
TREACHER, DF ;
TURNER, RC .
DIABETOLOGIA, 1985, 28 (07) :412-419
[8]   β-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus [J].
Nam, JH ;
Mun, JI ;
Kim, SI ;
Kang, SW ;
Choi, KH ;
Park, K ;
Ahn, CW ;
Cha, BS ;
Song, YD ;
Lim, SK ;
Kim, KR ;
Lee, HC ;
Huh, KB .
TRANSPLANTATION, 2001, 71 (10) :1417-1423
[9]  
National Institutes of Health N. I. o. D. a. D. a. K. D. U.S., USRDS 2012 ANN DAT R
[10]   Methods for clinical assessment of insulin sensitivity and β-cell function [J].
Pacini, G ;
Mari, A .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 17 (03) :305-322